Dotanift M 80mg/250mg Tablet
Marketer
Curavax Pharmaceuticals Private Limited
Salt Composition
Drotaverine (80mg) + Mefenamic Acid (250mg)
Overview Dotanift M 80mg/250mg Tablet
Abdominal pain is effectively treated with the combined medication, Dotanift M 80mg/250mg Tablet. This formulation alleviates abdominal pain, bloating, discomfort, and cramping by relaxing gastrointestinal muscles and inhibiting pain-inducing chemical signals. Administered with food, the dosage and duration of Dotanift M 80mg/250mg Tablet should strictly adhere to your physician's instructions. Treatment should continue as directed; premature cessation may lead to symptom recurrence and condition exacerbation. Comprehensive disclosure of all other medications to your healthcare provider is crucial, as interactions are possible. Common, typically transient side effects include diarrhea, nausea, vomiting, stomach pain, dry mouth, appetite loss, thirst, and heartburn. Report any concerning side effects immediately. Dizziness and drowsiness are potential side effects; avoid driving or mentally demanding tasks until their impact is known. Alcohol consumption should be avoided due to potential dizziness exacerbation. Inform your doctor of pregnancy, pregnancy plans, or breastfeeding before commencing treatment. Kidney or liver conditions should also be disclosed to ensure appropriate dosage adjustments.
Primary Ingredients of Dotanift M 80mg/250mg Tablet
The provided text is "undefined," therefore no rephrasing is possible.
Uses of Dotanift M 80mg/250mg Tablet
Managing abdominal discomfort
Major Benefits of Dotanift M 80mg/250mg Tablet:
Consume this medication precisely as your physician directs, adhering to the prescribed dosage and timeframe. Ingest the entire tablet; avoid chewing, crushing, or fracturing it. Dotanift M 80mg/250mg tablets should be administered with food.
Common Side effects of Dotanift M 80mg/250mg Tablet:
- Nausea
- Vomiting
- Diarrhea
- Dryness in mouth
- Heartburn
- Vertigo
- Insomnia (difficulty in sleeping)
- Hypotension (low blood pressure)
- Fast heart rate
- Sweating
- Constipation
- Increased liver enzymes
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Purpura
- Agranulocytosis (deficiency of granulocytes in the blood)
- Breathlessness
- Ringing in ear
- Abdominal pain
- Flatulence
- Indigestion
- Stomach inflammation
- Confusion
- Depression
How to use Dotanift M 80mg/250mg Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It is recommended to take Dotanift M 80mg/250mg Tablet with a meal.
How Dotanift M 80mg/250mg Tablet works:
Each Dotanift M 80mg/250mg tablet combines drotaverine and mefenamic acid to alleviate abdominal pain and cramping. Drotaverine, an antispasmodic, targets abdominal smooth muscle spasms, easing contractions. Mefenamic acid, a non-steroidal anti-inflammatory drug (NSAID), reduces pain and inflammation by inhibiting the production of inflammatory mediators.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol while taking Dotanift M 80mg/250mg tablets is unsafe.
PregnancyCONSULT YOUR DOCTOR
The use of Dotanift M 80mg/250mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the potential advantages against the risks before prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Data on the safety of Dotanift M 80mg/250mg Tablet while breastfeeding is currently unavailable. Seek medical advice from your physician.
DrivingUNSAFE
Taking Dotanift M 80mg/250mg tablets might lead to adverse reactions that impair driving ability, as dizziness is a potential side effect.
KidneyCAUTION
Patients with impaired kidney function should exercise caution when using Dotanift M 80mg/250mg tablets, as dosage modification may be necessary. Consult your physician for guidance. The use of Dotanift M 80mg/250mg tablets is contraindicated in individuals with severely compromised renal function.
LiverCAUTION
Patients with hepatic impairment should exercise caution when using Dotanift M 80mg/250mg tablets. Dosage modification of Dotanift M 80mg/250mg tablets may be necessary. Physician consultation is advised.
What if you forget to take Dotanift M 80mg/250mg Tablet :
Should you forget to take a Dotanift M 80mg/250mg Tablet, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Dotanift M 80mg/250mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Gastrointestinal system |
3,018 People bought this recently